Please login to the form below

Not currently logged in

Bristol Myers-Squibb

This page shows the latest Bristol Myers-Squibb news and features for those working in and with pharma, biotech and healthcare.

EU approval for Opdivo combo in renal cell cancer

EU approval for Opdivo combo in renal cell cancer

BMS one step ahead of rivals. The European Commission has approved the combination of Bristol-Myers Squibb’s Opdivo and Yervoy for the first-line treatment of patients with intermediate- and

Latest news

More from news
Approximately 128 fully matching, plus 815 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 4 fully matching, plus 36 partially matching documents found.

Latest appointments

More from appointments
Approximately 10 fully matching, plus 100 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Top Pharma News is a global pharma magazine dedicated to delivering fresh news to society. The team at the cater non-biased,...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....